43.8 USD
+0.5 (+1.15%)
43.8 USD
0 (0%)
VCYT gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While VCYT has a great health rating, its profitability is only average at the moment. VCYT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make VCYT suitable for growth investing!
1. Profitability
1.1 Basic Checks
- VCYT had positive earnings in the past year.
- In the past year VCYT had a positive cash flow from operations.
- In the past 5 years VCYT reported 4 times negative net income.
- In multiple years VCYT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- VCYT has a Return On Assets of 2.22%. This is amongst the best in the industry. VCYT outperforms 89.33% of its industry peers.
- Looking at the Return On Equity, with a value of 2.41%, VCYT belongs to the top of the industry, outperforming 90.29% of the companies in the same industry.
- The Return On Invested Capital of VCYT (2.93%) is better than 90.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROIC | 2.93% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- VCYT has a Profit Margin of 6.12%. This is amongst the best in the industry. VCYT outperforms 90.10% of its industry peers.
- VCYT's Operating Margin of 9.70% is amongst the best of the industry. VCYT outperforms 91.62% of its industry peers.
- The Gross Margin of VCYT (68.53%) is better than 81.14% of its industry peers.
- In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
- The number of shares outstanding for VCYT has been increased compared to 1 year ago.
- The number of shares outstanding for VCYT has been increased compared to 5 years ago.
- VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 19.03 indicates that VCYT is not in any danger for bankruptcy at the moment.
- VCYT's Altman-Z score of 19.03 is amongst the best of the industry. VCYT outperforms 88.19% of its industry peers.
- VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 19.03 |
ROIC/WACC0.33
WACC8.9%
2.3 Liquidity
- VCYT has a Current Ratio of 6.23. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT's Current ratio of 6.23 is fine compared to the rest of the industry. VCYT outperforms 63.81% of its industry peers.
- VCYT has a Quick Ratio of 5.94. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT has a Quick ratio of 5.94. This is in the better half of the industry: VCYT outperforms 63.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 |
3. Growth
3.1 Past
- VCYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 353.33%, which is quite impressive.
- VCYT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.41%.
- The Revenue has been growing by 29.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
- Based on estimates for the next years, VCYT will show a very strong growth in Earnings Per Share. The EPS will grow by 51.21% on average per year.
- Based on estimates for the next years, VCYT will show a quite strong growth in Revenue. The Revenue will grow by 11.52% on average per year.
EPS Next Y79.07%
EPS Next 2Y88.85%
EPS Next 3Y64.96%
EPS Next 5Y51.21%
Revenue Next Year14.79%
Revenue Next 2Y13.07%
Revenue Next 3Y12.72%
Revenue Next 5Y11.52%
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- VCYT is valuated quite expensively with a Price/Earnings ratio of 115.26.
- Based on the Price/Earnings ratio, VCYT is valued cheaply inside the industry as 89.71% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Earnings ratio of 27.32, VCYT is valued quite expensively.
- Based on the Price/Forward Earnings ratio of 40.94, the valuation of VCYT can be described as expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.43% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.32. VCYT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 115.26 | ||
| Fwd PE | 40.94 |
4.2 Price Multiples
- 91.81% of the companies in the same industry are more expensive than VCYT, based on the Enterprise Value to EBITDA ratio.
- VCYT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. VCYT is cheaper than 93.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.34 | ||
| EV/EBITDA | 42.85 |
4.3 Compensation for Growth
- VCYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of VCYT may justify a higher PE ratio.
- VCYT's earnings are expected to grow with 64.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.46
PEG (5Y)N/A
EPS Next 2Y88.85%
EPS Next 3Y64.96%
5. Dividend
5.1 Amount
- No dividends for VCYT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
43.8
+0.5 (+1.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)01-11 2026-01-11/amc
Earnings (Next)05-05 2026-05-05/amc
Inst Owners114.83%
Inst Owner Change-0.22%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap3.46B
Revenue(TTM)495.14M
Net Income(TTM)30.31M
Analysts82.11
Price Target49.7 (13.47%)
Short Float %6.34%
Short Ratio5.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0.75%
PT rev (3m)18.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.94%
EPS NY rev (1m)1.3%
EPS NY rev (3m)40.54%
Revenue NQ rev (1m)0.54%
Revenue NQ rev (3m)1.04%
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)1.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 115.26 | ||
| Fwd PE | 40.94 | ||
| P/S | 6.99 | ||
| P/FCF | 35.34 | ||
| P/OCF | 32.14 | ||
| P/B | 2.75 | ||
| P/tB | 8.7 | ||
| EV/EBITDA | 42.85 |
EPS(TTM)0.38
EY0.87%
EPS(NY)1.07
Fwd EY2.44%
FCF(TTM)1.24
FCFY2.83%
OCF(TTM)1.36
OCFY3.11%
SpS6.26
BVpS15.91
TBVpS5.04
PEG (NY)1.46
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.22% | ||
| ROE | 2.41% | ||
| ROCE | 3.71% | ||
| ROIC | 2.93% | ||
| ROICexc | 4.08% | ||
| ROICexgc | 54.52% | ||
| OM | 9.7% | ||
| PM (TTM) | 6.12% | ||
| GM | 68.53% | ||
| FCFM | 19.79% |
ROA(3y)-2.66%
ROA(5y)-4.4%
ROE(3y)-2.83%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.07% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.6% | ||
| Profit Quality | 323.21% | ||
| Current Ratio | 6.23 | ||
| Quick Ratio | 5.94 | ||
| Altman-Z | 19.03 |
F-Score8
WACC8.9%
ROIC/WACC0.33
Cap/Depr(3y)39.24%
Cap/Depr(5y)36.19%
Cap/Sales(3y)2.72%
Cap/Sales(5y)2.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y79.07%
EPS Next 2Y88.85%
EPS Next 3Y64.96%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.79%
Revenue Next 2Y13.07%
Revenue Next 3Y12.72%
Revenue Next 5Y11.52%
EBIT growth 1Y427.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year319.96%
EBIT Next 3Y74.15%
EBIT Next 5Y48.27%
FCF growth 1Y236.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y180.39%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for VCYT stock?
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 115.26 and the Price/Book (PB) ratio is 2.75.
What is the financial health of VERACYTE INC (VCYT) stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.